Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusion.

Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusion. Cancer Res. 2012 Jan 15; 72(2):402-7.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.